Therapeutic Outcome of Alemtuzumab in Korean Patients with Multiple Sclerosis: 2-Year Follow-Up

BACKGROUND AND PURPOSE: Alemtuzumab has shown high efficacy in clinical trials that primarily involved Western multiple sclerosis (MS) patients. To evaluate the therapeutic outcome of alemtuzumab in Korean patients with MS. METHODS: This study enrolled 23 consecutive patients who were treated with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyun, Jae-Won, Shin, Hyun-June, Jang, Hyunmin, Park, Na Young, Kim, Su-Hyun, Kim, Ho Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620458/
https://www.ncbi.nlm.nih.gov/pubmed/31286704
http://dx.doi.org/10.3988/jcn.2019.15.3.328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620458/
https://www.ncbi.nlm.nih.gov/pubmed/31286704
http://dx.doi.org/10.3988/jcn.2019.15.3.328

Ejemplares similares